Anderson Schock
Stock Analyst at B. Riley Securities
(1.60)
# 3,204
Out of 5,184 analysts
42
Total ratings
43.2%
Success rate
-0.2%
Average return
Main Sectors:
Stocks Rated by Anderson Schock
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VREX Varex Imaging | Downgraded: Hold | $18 → $19 | $18.10 | +4.42% | 5 | Aug 10, 2026 | |
| LFMD LifeMD | Reiterated: Buy | $10 → $8 | $1.45 | +453.63% | 2 | Aug 6, 2026 | |
| INFU InfuSystem Holdings | Rated: Buy | $12 → $20 | $14.35 | +39.37% | 3 | Aug 5, 2026 | |
| XGN Exagen | Rated: Buy | $8 → $12 | $3.61 | +232.41% | 5 | Aug 5, 2026 | |
| ANIK Anika Therapeutics | Reiterated: Buy | $18 → $21 | $13.23 | +58.73% | 4 | Jul 30, 2026 | |
| NUTX Nutex Health | Initiated Coverage: Buy | $290 | $162.64 | +78.31% | 1 | Jun 26, 2026 | |
| CLPT ClearPoint Neuro | Reiterated: Buy | $20 → $30 | $6.91 | +334.15% | 5 | Jun 17, 2026 | |
| OBIO Orchestra BioMed Holdings | Reiterated: Buy | $10 | $6.58 | +51.98% | 1 | May 18, 2026 | |
| ELMD Electromed | Reiterated: Buy | $38 → $40 | $22.98 | +74.06% | 2 | May 13, 2026 | |
| OPRX OptimizeRx | Reiterated: Buy | $11 → $10 | $6.70 | +49.25% | 4 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $32 → $36 | $25.60 | +40.63% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4 | $0.2751 | +1,354.02% | 1 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $14 | $10.76 | +30.11% | 1 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $0.68 | +635.29% | 1 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $5.30 | +164.15% | 3 | Jan 21, 2026 |
Varex Imaging
Aug 10, 2026
Downgraded: Hold
Price Target: $18 → $19
Current: $18.10
Upside: +4.42%
LifeMD
Aug 6, 2026
Reiterated: Buy
Price Target: $10 → $8
Current: $1.45
Upside: +453.63%
InfuSystem Holdings
Aug 5, 2026
Rated: Buy
Price Target: $12 → $20
Current: $14.35
Upside: +39.37%
Exagen
Aug 5, 2026
Rated: Buy
Price Target: $8 → $12
Current: $3.61
Upside: +232.41%
Anika Therapeutics
Jul 30, 2026
Reiterated: Buy
Price Target: $18 → $21
Current: $13.23
Upside: +58.73%
Nutex Health
Jun 26, 2026
Initiated Coverage: Buy
Price Target: $290
Current: $162.64
Upside: +78.31%
ClearPoint Neuro
Jun 17, 2026
Reiterated: Buy
Price Target: $20 → $30
Current: $6.91
Upside: +334.15%
Orchestra BioMed Holdings
May 18, 2026
Reiterated: Buy
Price Target: $10
Current: $6.58
Upside: +51.98%
Electromed
May 13, 2026
Reiterated: Buy
Price Target: $38 → $40
Current: $22.98
Upside: +74.06%
OptimizeRx
May 13, 2026
Reiterated: Buy
Price Target: $11 → $10
Current: $6.70
Upside: +49.25%
May 7, 2026
Upgraded: Buy
Price Target: $32 → $36
Current: $25.60
Upside: +40.63%
Mar 31, 2026
Initiated Coverage: Buy
Price Target: $4
Current: $0.2751
Upside: +1,354.02%
Feb 26, 2026
Downgraded: Hold
Price Target: $14
Current: $10.76
Upside: +30.11%
Feb 10, 2026
Initiated Coverage: Buy
Price Target: $5
Current: $0.68
Upside: +635.29%
Jan 21, 2026
Reiterated: Buy
Price Target: $14
Current: $5.30
Upside: +164.15%